W Health Ventures closes second fund
Analysis based on 9 articles · First reported Sep 07, 2026 · Last updated Sep 08, 2026
The successful oversubscribed fund close signals strong investor confidence in India's healthcare sector and the company-creation model, potentially boosting sentiment for healthcare startups and venture capital activity in the region. It may also encourage similar fundraises and increase competition in early-stage healthcare investing.
W Health Ventures, a healthcare-focused venture capital firm based in Mumbai, announced the final close of its second fund at Rs 700 crore (about $84 million), surpassing its initial target of Rs 630 crore. The fund, launched in July 2025 and registered as a Category II alternative investment fund with the India — Securities and Exchange Board of India, will deploy capital in ticket sizes of Rs 30-50 crore over a four-year investment period to build 8-10 healthcare companies from the pre-idea stage to category leaders. The firm's company-creation model involves identifying structural gaps in healthcare delivery, pressure-testing opportunities for 12-18 months, and then assembling founding teams. Under Fund II, W Health Ventures has already incubated two companies: Everhope Oncology, a cancer care platform built in partnership with Narayana Health, and China Everbright Group, a US-based mental health platform. The fund is backed by family offices and institutional investors from India and the US. W Health Ventures' portfolio companies have reached 25 million patients, and the firm plans to focus on themes such as using AI to bridge India's healthcare supply-demand gaps and building India into a healthcare superpower.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard